Related Experiment Video

Updated: Feb 27, 2026

TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism
10:58

TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism

Published on: December 28, 2010

17.5K

Coupling Timing of Interventions With Dose to Optimize Plasticity and Participation in Pediatric Neurologic

Mary E Gannotti1

  • 1Department of Rehabilitation Sciences, University of Hartford, West Hartford, Connecticut.

Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association
|June 28, 2017
PubMed

Insights

Optimizing intervention timing and dosage in pediatric cerebral palsy enhances neuroplasticity and participation. This approach focuses on maximizing functional gains and participation across the lifespan for improved outcomes.

Area of Science:

  • Pediatric Neurology
  • Rehabilitation Science
  • Neuroplasticity Research

Background:

  • Pediatric neurologic conditions, such as cerebral palsy, require tailored interventions.
  • Optimizing plasticity and participation is crucial for functional improvement.
  • Understanding developmental periods is key to maximizing intervention effectiveness.

Purpose of the Study:

  • To propose coupling intervention timing with dosing for optimal plasticity and participation in pediatric neurologic conditions.
  • To review parameters for promoting bone, muscle, and brain plasticity.
  • To explore interventions targeting body structures, function, activity, and participation.

Main Methods:

  • Review of known parameters for promoting plasticity (bone, muscle, brain).
  • Examination of evidence supporting critical developmental growth periods.
  • Exploration of intervention dosing parameters (frequency, intensity, time, type).

Main Results:

  • Bone, muscle, and brain plasticity are influenced by specific parameters.
  • Critical growth periods offer enhanced potential for neuroplasticity.
  • Emerging evidence suggests high-intensity participation interventions can drive change.

Conclusions:

  • Coupling intervention timing with dosing optimizes plasticity and participation in pediatric cerebral palsy.
  • Participation interventions may offer lifelong avenues for promoting change.
  • Recommendations are provided for research and clinical practice innovation.
Abstract

More Related Videos

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

2.0K
Non-Invasive Modulation and Robotic Mapping of Motor Cortex in the Developing Brain08:26

Non-Invasive Modulation and Robotic Mapping of Motor Cortex in the Developing Brain

Published on: July 1, 2019

7.2K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
336
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
423
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
402